Emyria’s Specialist Psychiatrist Granted Authorised Prescriber Status in MDMA-Assisted Therapy for PTSD Life Science Investing
Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis Geography
Ocumetics Eyes First In-human Trials of Accommodating Lens Technology in Early 2024 Medical Device Investing
FDA approves Medtronic Percept RC neurostimulator with exclusive BrainSense technology Medical Device Investing
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients Medical Device Investing
Medtronic Diabetes announces world's first approval for MiniMed 780G System with Simplera Sync disposable, all-in-one sensor Medical Device Investing
Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute Pharmaceutical Investing
Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement Psychedelics Investing
Medtronic receives CE Mark for its next generation Micra leadless pacing systems Medical Device Investing
Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024 Medical Device Investing
